Among the 343 ALK fusion cases, complex ALK rearrangements in 14 cases were identified using targeted DNA-based NGS across 86 cancer-related genes panel with multiple probes tilling selected intronic regions of fusion partner genes (Table 2). The gene discussed is ALK; the disease is cancer.